Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment
Open Access
- 25 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (7), 913-915
- https://doi.org/10.1093/rheumatology/kei263
Abstract
Sir, We report a 9-yr-old girl with a severe relapsing–remitting course of neuromyelitis optica (NMO) [1–3] who had a dramatic and sustained improvement over a 2-yr period of treatment with mycophenolate mofetil (MMF), the prodrug of mycophenolic acid.Keywords
This publication has 9 references indexed in Scilit:
- Mycophenolate mofetil in lupus nephritisLupus, 2005
- Devic's Neuromyelitis Optica Treated with Intravenous Gamma Globulin (IVIG)Canadian Journal of Neurological Sciences, 2004
- Devic's neuromyelitis optica: study of nine casesActa Neurologica Scandinavica, 2003
- Neuromyelitis opticaNeurology, 2003
- Mycophenolate mofetil treatment in conditions different from organ transplantationTransplantation Proceedings, 2002
- Devic's disease: bridging the gap between laboratory and clinic.Brain, 2002
- Autoimmune DiseasesNew England Journal of Medicine, 2001
- The clinical course of neuromyelitis optica (Devic’s syndrome)Neurology, 1999
- Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprineNeurology, 1998